Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
hospimedica.com
Women's Health
Sponsored by
SIEMENS Healthcare
Features Subscription Partner Sites Journal Info
SIEMENS HEALTHCARE

Antidepressants in Pregnancy Increase Risk of Miscarriage

By HospiMedica International staff writers
Posted on 07 Jun 2010


A new study has found a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants.

Researchers from the University of Montreal (Canada) and the CHU Ste-Justine (Montreal, Canada) examined data on 5,124 women in Quebec (Canada) from a large population-based cohort of pregnant women who had clinically verified miscarriages at up to 20 weeks of gestation, and a large sample of women from the same registry who did not have a miscarriage. Of those who miscarried, 284 (5.5%) had taken antidepressants during pregnancy.

The researchers found that selective serotonin reuptake inhibitors (SSRIs), especially paroxetine and venlafaxine, were associated with increased risk of miscarriage, as were higher daily doses of either antidepressant; a combination of different antidepressants further doubled the risk of miscarriages. The researchers urged physicians who have patients of childbearing age taking antidepressants, or pregnant patients who require antidepressant therapy early in pregnancy, to discuss the risks and benefits with them. The study was published in the June 2010 issue of the Canadian Medical Association Journal (CMAJ).

“These results, which suggest an overall class effect of selective serotonin reuptake inhibitors, are highly robust given the large number of users studied,” said senior author Anick Bérard, Ph.D., and colleagues of the faculty of pharmacy at the University of Montreal.

SSRIs are typically used in the treatment of depression, anxiety disorders, and some personality disorders. They are also typically effective and used in treating premature ejaculation problems as well as some cases of insomnia. SSRIs increase the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor.

Related Links:

University of Montreal
CHU Ste-Justine






Visualization Software
Visualization Software
Surgical Lights
Surgical Lights
X-Ray Meter
X-Ray Meter

More Products

Latest Women's Health News

Latest Issue
View Digital Edition
Subscribe / Renew
LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured MedBiz Market Reports
Premium Report The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Premium Report Delivering Opportunities in the Inhalable Drugs Market: Innovative formulations and devices
Events
ERS 2010 - European Respiratory Society Annual Congress
18 Sep 2010
22 Sep 2010


2010 National Scientific Assembly of the American College of Emergency Physicians (ACEP)
28 Sep 2010
01 Oct 2010


Hospital 2010 – 15th International Healthcare Exhibition
05 Oct 2010
07 Oct 2010


More events
SIEMENS HEALTHCARE'
  hospimedica.com Copyright © 2000-2010 Globetech Media. All rights reserved.